Novel, selective 5-HT5A receptor antagonist as a potential treatment for schizophrenia March 18, 2014
A first-in-class melanocortin MC4 receptor agonist for the treatment of sexual dysfunction March 18, 2014
GLPG-0187 shows a favorable toxicity profile in phase I trials in patients with solid tumors March 17, 2014
RSS